Latitude Advisors, LLC Zoetis Inc. Transaction History

Latitude Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$155.97 - $200.09 $221,165 - $283,727	-1,418 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$181.39 - $234.03 $437,331 - $564,246	-2,411 Reduced 62.97%	1,418 $267,000
Q4 2021 Jan 18, 2022	BUY	$193.69 - $247.03 $59,462 - $75,838	307 Added 8.72%	3,829 $935,000
Q3 2021 Oct 14, 2021	BUY	$189.29 - $209.69 $368,169 - $407,847	1,945 Added 123.34%	3,522 $684,000
Q2 2021 Jul 20, 2021	BUY	$155.9 - $187.99 $23,073 - $27,822	148 Added 10.36%	1,577 $294,000
Q1 2021 Apr 14, 2021	BUY	$144.0 - $169.39 $205,776 - $242,058	1,429 New	1,429 $225,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Latitude Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Latitude Advisors, LLC with notifications on news.